TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs. April 30, 2004